Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis.

BMJ Open Ophthalmol · 2023 · PMC10277136 · PMID 37493653

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although hypersensitivity reactions occurred more frequently with ADA, it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.